In this issue:
Predicting clearance and remission duration with UVB phototherapy
Patient characteristics and burden of disease in generalised pustular psoriasis
Risk of retinal diseases in patients with psoriasis
Selectivity of TYK2 inhibitor vs JAK 1/2/3 inhibitors
Biological therapy interruption and re-treatment
Time to relapse of plaque psoriasis after biologic discontinuation
Guselkumab in Chinese patients with psoriasis
Oral simvastatin + narrowband UVB
Dermatological-rheumatological management of psoriasis and PsA
Please login below to download this issue (PDF)